Context Therapeutics is trading up 5.17% at $0.33 as of 9:48 a.m. ET on October 5, 2026, with no clear company-specific catalyst identified.
- The company’s investor-relations press-release listing shows no October 5 announcement; its latest listed release was September 9.
- Major indexes are mixed, and available evidence does not establish broader-market conditions as the reason for this individual stock move.